Video

Molecular Testing in Early NSCLC to Guide Treatment Decision Making

Jonathan Spicer, MD, explains the role of molecular testing in patients with stage I-IIIA NSCLC, and how it informs treatment decision-making.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.